Chord Therapeutics

Chord Therapeutics

Verified
Developing drugs for patients with rare, life-threatening, and severely disabling diseases

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$64—96m (Dealroom.co estimates Oct 2020.)
Geneva Canton of Geneva (HQ)
  • Edit
DateInvestorsAmountRound
N/AN/ASeed
$16mSeries A
*
N/AAcquisition
Total Funding$16m

Recent News about Chord Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.